Aitia

Aitia

Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$450k

Debt

$5.0m

Early VC

$9.9m

Series A

$10.0m

Series B
N/A

$750k

Debt
N/A

$8.1m

Early VC

$10.0m

Series C
N/A

$4.0m

Early VC

$6.0m

Early VC

$23.0m

Series D
Total FundingAUD117m

Recent News about Aitia

Edit
More about Aitiainfo icon
Edit

GNS Healthcare is a leading provider of AI-driven precision medicine solutions, focusing on optimizing drug discovery and improving healthcare outcomes. The company operates in the healthcare and pharmaceutical markets, serving clients such as pharmaceutical companies, healthcare providers, and insurance firms. GNS Healthcare leverages advanced machine learning and big data analytics to create predictive models that help in identifying effective treatments and improving patient care. The business model revolves around offering software-as-a-service (SaaS) solutions and consulting services, generating revenue through subscription fees and project-based engagements. By integrating vast amounts of clinical and genomic data, GNS Healthcare enables its clients to make data-driven decisions, ultimately enhancing the efficiency and effectiveness of healthcare delivery.

Keywords: AI, precision medicine, drug discovery, healthcare outcomes, machine learning, big data, predictive models, SaaS, genomic data, data-driven decisions.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.